Here, Deepak A. Rao & team use mass cytometry immune profiling to identify T cell features in pre-treatment blood samples from patients that are associated with irAEs after ICI therapy.
1Division of Rheumatology, Inflammation, Immunity, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts, USA.
2Division of Rheumatology, Hospital for Special Surgery and Weill Cornell Medicine, New York, New York, USA.
3Memorial Sloan Kettering Center and Weill Cornell Medical College, New York, New York, USA.